Pfizer testing Omicron-based vaccine amid concerns about twin variant

Pfizer has started testing an Omicron-based COVID-19 vaccine to see if it can prevent infection and not only severe illness. The testing comes as researchers investigate an emerging variant described as Omicron’s twin.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting